Tolerances for Residues of New Animal Drugs in Food; Apramycin

Özet

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of two supplemental new animal drug applications (NADA's) filed by Elanco Animal Health, A Division of Eli Lilly & Co. The supplemental NADA's provide for revised tolerances for total residues of apramycin (i.e., the safe concentration) in edible swine tissues.